Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans
- PMID: 29380822
- PMCID: PMC6522224
- DOI: 10.1038/ajg.2017.456
Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans
Abstract
Objectives: The healthcare burden of autoimmune hepatitis (AIH) in the United States has not been characterized. We previously showed that AIH disproportionately affects people of color in a single hospital system. The current study aimed to determine whether the same disparity occurs nationwide.
Methods: We analyzed hospitalizations with a primary discharge diagnosis corresponding to the ICD-9 code for AIH in the National Inpatient Sample between 2008 and 2012. For each racial/ethnic group, we calculated the AIH hospitalization rate per 100,000 population and per 100,000 all-cause hospitalizations, then calculated a risk ratio compared to the reference rate among whites. We used multivariable logistic regression models to assess for racial disparities and to identify predictors of in-hospital mortality during AIH hospitalizations.
Results: The national rate of AIH hospitalization was 0.73 hospitalizations per 100,000 population. Blacks and Latinos were hospitalized for AIH at a rate 69% (P<0.001) and 20% higher (P<0.001) than whites, respectively. After controlling for age, gender, payer, residence, zip code income, region, and cirrhosis, black race was a statistically significant predictor for mortality during AIH hospitalizations (odds ratio (OR) 2.81, 95% confidence interval (CI) 1.43, 5.47).
Conclusions: Hospitalizations for AIH disproportionately affect black and Latino Americans. Black race is independently associated with higher odds of death during hospitalizations for AIH. This racial disparity may be related to biological, genetic, environmental, socioeconomic, and healthcare access and quality factors.
Conflict of interest statement
CONFLICT OF INTEREST
Robert Wong: critical revision of manuscript and statistical analysis. Ma Somsouk: critical revision of manuscript and statistical analysis. Mandana Khalili: critical revision of manuscript and statistical analysis. Jacquelyn Maher: critical revision of manuscript and statistical analysis. Michele Tana: study concept and design, acquisition of data, critical revision of manuscript and statistical analysis, study supervision.
Figures
References
-
- Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929–38. - PubMed
-
- Czaja AJ, Manns MP Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010;139:58–72.e54. - PubMed
-
- Gronbaek L, Vilstrup H, Jepsen P Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol 2014;60:612–7. - PubMed
-
- Lim KN, Casanova RL, Boyer TD et al. Autoimmune hepatitis in African Americans: presenting features and response to therapy. Am J Gastroenterol 2001;96:3390–4. - PubMed
-
- Munoz-Espinosa LE, Cordero-Perez P, Cura-Esquivel I et al. Autoimmune hepatitis in Mexican patients. J Clin Gastroenterol 2013;47:372. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources